In order to prove the implication of John Cunningham virus in colorectal cancer of Iraqi patients. Sixty eight (68) formalin-fixed, paraffin embedded colorectal tissues were obtained in this study ;42 biopsies from colorectal carcinoma (CRC) and (16) from benign colorectal tumors as well as (10) apparently normal colorectal autopsies control group. The
Abdullah, Zahraa Ali +1 more
openaire +1 more source
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis. [PDF]
Gelissen LMY +30 more
europepmc +1 more source
Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate. [PDF]
Farley S +7 more
europepmc +1 more source
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based Study. [PDF]
Kartau M +7 more
europepmc +1 more source
"Pardon My Language": The Curious Case of a Bloody Sandwich and the John Cunningham Virus Reactivation in the Era of Immunomodulatory Drugs. [PDF]
Guerra-Bauman F +5 more
europepmc +1 more source
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet. [PDF]
Pasca M +9 more
europepmc +1 more source
Progressive multifocal leukoencephalopathy secondary to rituximab-induced immunosuppression and the presence of John Cunningham virus: a case report and literature review. [PDF]
Kelly D +7 more
europepmc +1 more source
Progressive Multifocal Leukoencephalopathy Mimicking Stroke in a Patient With Newly Diagnosed HIV: A Case Report. [PDF]
Hlaing T, Maung T.
europepmc +1 more source
Iron limitation differentially affects viral replication in key marine microbes. [PDF]
Yung CCM +6 more
europepmc +1 more source
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab. [PDF]
Høgestøl EA +12 more
europepmc +1 more source

